China’s Medical Rehabilitation Robot Market is Poised for Rapid Development

China’s medical rehabilitation robot market is poised for rapid development, supported by favorable policies and technological advancements, according to a recent report from consultancy Frost & Sullivan.

The report forecasts that the market will reach 2.04 billion yuan ($296.7 million) this year and 7.95 billion yuan by 2026, with an estimated compound annual growth rate of 57.5 percent. This represents a significant increase from the 210 million yuan market scale in 2018.

The report also highlighted an increase in capital flowing into the sector. In 2022, there were 10 investment deals in China’s medical rehabilitation sector, a record high, according to healthcare services platform VBData.cn, based in Chongqing. As of the end of March, there have been three investment deals, with the total value surpassing 200 million yuan, setting a new record in terms of quarterly investment numbers and value.

The Chinese government has launched a series of policies to boost the development of rehabilitation robots between 2015 and 2023, including supporting relevant research and development, promoting technological development, allocating resources for rehabilitation centers, and formulating standards of rehabilitation treatment.

Despite this, supply is still incapable of meeting demand. The Lancet Public Health reported that there are more than 460 million people in China with rehabilitation demands, including the elderly, the postoperative, and those with chronic diseases and disabilities. The China Health Statistics Yearbook revealed that there were only 49,000 rehabilitation healthcare professionals in China in 2020, accounting for only 1.2 percent of the total healthcare professionals in the country.

This has led to an increase in domestic companies ramping up R&D efforts in medical rehabilitation robots. For example, Angelexo, based in Hangzhou, Zhejiang province, develops rehabilitation robots for patients with hemiplegia, while Shanghai Siyi Intelligence Technology Co Ltd launched a robot based on a brain-computer interface that collects and records brain signals in real-time and converts the signals into motion instructions to assist patient mobility.

Shanghai Bangbang Robotics also developed movement-assisting robots that can help disabled individuals with mobility difficulties to stay at home more comfortably, as well as travel-assisting robots that can help those with mobility challenges complete safe and stable travel.

“With society aging faster, the demand for rehabilitation robots is expected to continue to grow,” said VBData.cn analyst Cui Lulu. To realize sustainable development, Cui emphasized that firms should focus on technological innovation and product differentiation, raise product performance and quality, and improve market competitiveness.

She also suggested that enterprises work with hospitals and rehabilitation institutions, learn more about market demand and user feedback, and constantly optimize their products and services.

The increasing demand for medical rehabilitation robots is attributed to China’s aging population, which is growing at an unprecedented rate. With more than 460 million people in China requiring rehabilitation, the market has tremendous potential for growth. The report from Frost & Sullivan also notes that the industry potential is vast, with low market concentration.

Domestic companies are taking advantage of this potential and are investing in R&D to develop innovative and advanced rehabilitation robots that cater to the increasing demand. As more companies enter the market, there is a need to improve product performance and quality, in addition to increasing market competitiveness.

To achieve sustainable growth, Cui Lulu advised enterprises to collaborate with rehabilitation institutions and hospitals, to gain more insight into market demand and user feedback. By doing so, companies can optimize their products and services, as well as differentiate themselves from competitors.

The favorable policies from the government have provided much-needed support for the development of medical rehabilitation robots. The policy initiatives have encouraged research and development, technological innovation, and the allocation of resources to rehabilitation centers. With these policies in place, the industry is expected to grow significantly over the next few years.

The increasing capital inflow into the sector is also a significant indicator of the growth potential in the market. Investors are showing confidence in the potential of the medical rehabilitation robot market, making record investments in the sector.

In conclusion, the medical rehabilitation robot market in China is expected to grow rapidly, driven by favorable policies and technological advancements. With the increasing demand for rehabilitation services and the aging population, there is enormous potential for growth in the market.

Domestic companies need to focus on innovation, product differentiation, and improving product performance and quality to remain competitive in this fast-growing market.